Details for New Drug Application (NDA): 213927
✉ Email this page to a colleague
The generic ingredient in VENLAFAXINE HYDROCHLORIDE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
Summary for 213927
Tradename: | VENLAFAXINE HYDROCHLORIDE |
Applicant: | Dexcel |
Ingredient: | venlafaxine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 213927
Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 213927
Suppliers and Packaging for NDA: 213927
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213927 | ANDA | Lannett Company, Inc. | 0527-2606 | 0527-2606-32 | 30 TABLET in 1 BOTTLE (0527-2606-32) |
VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213927 | ANDA | Lannett Company, Inc. | 0527-2606 | 0527-2606-46 | 90 TABLET in 1 BOTTLE (0527-2606-46) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Jan 21, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription